From: Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
Mean changes | Intervention group | Control group | Difference in average means change from T0/T1 (intervention vs. control) | Confidence interval | Significance p | ||||
---|---|---|---|---|---|---|---|---|---|
Number of GP practices | 17 | 17 | 17 | 19 | 18 | 18 | |||
Primary endpoints | |||||||||
SDM-Q-9 | T1-T0 | T2-T0 | T3-T0 | T1-T0 | T2-T0 | T3-T0 | T0 | ||
Valid N | 320 | 287 | 256 | 337 | 272 | 246 | |||
Mean change | −0.11 | −2.875 | −1.07 | −4.06 | −2.34 | −3.69 | 3.1182 | −2.3730; 8.6093 | 0.2029 |
(SD) | (21.45) | (22.98) | (21.50) | (22.51) | (20.73) | (20.87) | |||
Systolic BP | T2-T1 | T3-T1 | T2-T1 | T3-T1 | T1 | ||||
Valid N | 414 | 381 | 376 | 337 | |||||
Mean change in mmHg | 0.59 | 0.43 | −0.02 | −0.81 | 1.7517 | −0.1884; 3.6918 | 0.0430 | ||
(SD) | (11.54) | (12.08) | (10.60) | (10.92) | |||||
Secondary endpoints | |||||||||
Diastolic BP | T2-T1 | T3-T1 | T2-T1 | T3-T1 | T1 | ||||
Valid N | 414 | 381 | 376 | 337 | |||||
Mean change in mmHg | −0.20 | −0.15 | −0.15 | −0.66 | 0.9377 | −0.0381; 1.9134 | 0.0596 | ||
(SD) | (6.74) | (6.14) | (6.14) | (5.86) | |||||
CVR | T2-T1 | T3-T1 | T2-T1 | T3-T1 | T1 | ||||
Valid N | 294 | 282 | 255 | 212 | |||||
Mean change in % | 0.71 | 1.44 | 1.14 | 2.04 | −0.4891 | −1.4307; 0.4526 | 0.3084 | ||
(SD) | (5.43) | (6.89) | (5.58) | (8.50) | |||||
MARS-D | T2-T1 | T3-T1 | T2-T1 | T3-T1 | T1 | ||||
Valid N | 360 | 320 | 313 | 287 | |||||
Mean change | 0.07 | 0.4 | −0.3 | −1.1 | 0.670 | −0.3748; 1.7166 | 0.2084 | ||
(SD) | (9.6) | (10.7) | (6.9) | (6.7) | |||||
Knowledge | T1-T0 | T2-T0 | T3-T0 | T1-T0 | T2-T0 | T3-T0 | T0 | ||
Valid N | 446 | 402 | 363 | 428 | 369 | 330 | |||
Mean change | 3.00 | 2.99 | 5.85 | 3.30 | 3.76 | 4.66 | 1.3267 | −4.3272; 6.9806 | 0.6454 |
(SD) | (27.71) | (28.56) | (28.44) | (30.00) | (28.37) | (24.49) |